On August 20, 2025, Vice President Han Zheng met with Chair of the Board of Directors of Novo Nordisk of Denmark Helge Lund in Beijing.

Han Zheng noted that in May this year, President Xi Jinping replied to the head of the Danish Chamber of Commerce in China (DCCC), encouraging the DCCC and its member enterprises to make new contributions to enhancing China-Denmark and China-Europe friendship and deepening mutually beneficial cooperation. China and Denmark, as well as China and Europe, are highly complementary in economy, with broad prospects for cooperation. By continuously deepening reform and pursuing higher-standard opening up, China will provide huge development opportunities for enterprises from all over the world, including Novo Nordisk. China has always placed the protection of people's health as a strategic priority for development. It has built the world's largest basic health care insurance network with universal coverage, and has seen continuous rises in average life expectancy. Han Zheng welcomed Novo Nordisk and other globally renowned biopharmaceutical companies to strengthen cooperation with China.

Helge Lund spoke highly of the achievements in China's economic and social development in recent years, stating that Novo Nordisk will continue to explore the Chinese market, expand investment in China, and achieve mutual benefit and win-win results.